The Framingham cardiovascular risk score in multiple sclerosis.
Moccia M, Lanzilloa R, Palladino R et al.
Federico II University, Naples, Italy.
Eur J Neurol 2015;22:1176–83.
Melinda Magyari’s review: The main aim of this study was to assess the global cardiovascular risk in persons with multiple sclerosis (MS) using the Framingham Risk Score (FRS), a standardized algorithm estimating an individual’s percentage risk of experiencing cardiovascular events (coronary, cerebrovascular, peripheral arterial disease, or heart failure) in the next 10 years (Circulation 2008;117:743–53). A higher risk of cardiovascular comorbidities in patients with MS has been reported in previous studies, and vascular comorbidities seem to influence disability development and progression (Neurology 2010;74:1041–7).